FDA Adverse Event Injury Summary report: N

SCREW, FIXATION, BONE

MDR report key: 5675643 · Received May 24, 2016

Report

Report Number
2520274-2016-12820
Event Type
Injury
Date Received
May 24, 2016
Date of Event
June 18, 2015
Report Date
May 17, 2016
Manufacturer
SYNTHES USA
Product Code
HWC
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. THIS REPORT IS FOR UNKNOWN SCREWS, UNKNOWN QUANTITY, UNKNOWN LOT. OTHER NUMBER: UDI: UNKNOWN PART NUMBER, UDI IS UNAVAILABLE. THE INVESTIGATION COULD NOT BE COMPLETED AND NO CONCLUSION COULD BE DRAWN, AS NO DEVICE WAS RETURNED AND NO LOT NUMBER OR PART NUMBER WAS PROVIDED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

LITERATURE ARTICLE RECEIVED. THIS REPORT IS BEING FILED AFTER THE SUBSEQUENT REVIEW OF THE FOLLOWING LITERATURE ARTICLE: BOESMUELLER, S. ET AL. (2015). PLATE FAILURE FOLLOWING PLATE OSTEOSYNTHESIS IN PERIPROSTHETIC FEMORAL FRACTURES. WIEN KLIN WOCHENSCHR. 127:770-778. AUSTRIA AND GERMANY. THE AIM OF THIS RETROSPECTIVE STUDY IS TO INVESTIGATE THE PATIENTS' OUTCOMES AFTER PLATE FAILURE. SEVEN OUT OF 80 PATIENTS TREATED WITH PLATE OSTEOSYNTHESIS FOLLOWING PERIPROSTHETIC FEMORAL FRACTURES (PPFF) BETWEEN JANUARY 2000 AND JUNE 2010 MET INCLUSION CRITERION. ALL SEVEN PATIENTS SUFFERING FROM A REFRACTURE WERE FEMALE, WITH AN AVERAGE AGE OF 74 (RANGE, 49-88) AT INITIAL SURGERY. PATIENT 5: FEMALE, (B)(6): AFTER 5 MONTHS AFTER BEING FIXED WITH A 17-HOLE TITANIUM LC-DCP (DEPUY SYNTHES, (B)(4)), MULTIPLE SCREW BREAKAGE WAS DIAGNOSED RADIOGRAPHICALLY RESULTING IN NON-UNION. THIS IS REPORT 3 OF 6 FOR (B)(4). THIS REPORT IS FOR UNKNOWN SCREWS. THIS REPORT IS FOR 6 DEVICES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
332088 SCREW, FIXATION, BONE HWC SYNTHES USA

Patients

Seq Age Sex Outcome Treatment
1 73 YR Required Intervention